Multiple myeloma (MM) is the second most common hematological malignant (HM) tumor, and a large proportion of patients still suffer from treatment failure and a poor prognosis despite the use of some newly approved drugs, a deeper understanding of the underlying mechanism is still needed. ...
Non-excretory myeloma is a rare variety of multiple myeloma in which classical techniques of research of the stigmata of chronic secretion fail to highligh... ME Euch,FBF Ismail,A Rezgui,... - 《内科学期刊(英文)》 被引量: 2发表: 2012年 CLINICOETIOLOGICAL EVALUATION OF THE PATIENTS OF MACR...
Elranatamab monotherapy in the real-word setting in relapsed-refractory multiple myeloma: results of the French compassionate use program on behalf of the IFM Florent Malard Arthur Bobin Mohamad Mohty CorrespondenceOpen Access18 Dec 2024Blood Cancer Journal ...
① t(11;14) 易位发生在20%的多发性骨髓瘤(multiple myeloma,MM)患者中,并导致CCND1上调。将近三分之二的t(11;14) MM细胞被BCL2激活,并且对口服BCL2抑制剂维奈托克(ventoclax)具有很高的反应。很明显,这种对ventoclax的独特敏感性依赖于BCL2的BH3促凋亡蛋白启动,但t(11;14) MM对BCL2依赖的生物学基础尚...
① t(11;14) 易位发生在20%的多发性骨髓瘤(multiple myeloma,MM)患者中,并导致CCND1上调。将近三分之二的t(11;14) MM细胞被BCL2激活,并且对口服BCL2抑制剂维奈托克(ventoclax)具有很高的反应。很明显,这种对ventoclax的独特敏感性依赖于BCL2的BH3促凋亡蛋白启动,但t(11;14) MM对BCL2依赖的生物学基础尚...
Multiple myeloma (MM) is a hematological cancer characterized by the abnormal proliferation of plasma cells. Initial treatments often include immunomodulatory drugs (IMiDs), proteasome inhibitors (PIs), and monoclonal antibodies (mAbs). Despite salient p
Elranatamab monotherapy in the real-word setting in relapsed-refractory multiple myeloma: results of the French compassionate use program on behalf of the IFM Florent Malard Arthur Bobin Mohamad Mohty CorrespondenceOpen Access18 Dec 2024Blood Cancer Journal ...
On March 26, 2021, the FDA approved ide-cel as the first BCMA-directed CAR T-cell therapy for patients with relapsed/refractory multiple myeloma after 4 or more prior lines of therapy, including an immunomodulatory agent (IMiD), a proteasome inhibitor (PI), and an anti-CD38 monoclo...
But uncertainty exists regarding the efficacy of this approach because there is substantial heterogeneity with respect to acupuncture treatment regimens, and more high-quality studies on this topic are warranted. Keywords: multiple myeloma peripheral neuropathy acupuncture pain systematic review Previous ...
Big Research December 16, 2024 Betulinic Acid Antioxidant Effect November 25, 2024 Benfotiamine Protection from Parkinson’s October 21, 2024 Ginsenoside Rg1 on Multiple Myeloma About LKT Labs LKT Laboratories is a biochemical supply company focused on the synthesis, purification, and isolation of smal...